[立体定向放射治疗新生血管性年龄相关性黄斑变性（STAR试验）能否提高生活质量？] - Suppr

Suppr

超能文献

[Can stereotactic radiotherapy for neovascular age-related macular degeneration (STAR trial) enhance quality of life?].

作者信息

Göller Stephanie, Schmidberger Heinz

机构信息

Klinik für Radioonkologie und Strahlentherapie, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.

Arbeitsgruppe junge DEGRO, Deutsche Gesellschaft für Radioonkologie e. V. (DEGRO), Berlin, Deutschland.

出版信息

Strahlenther Onkol. 2025 Mar;201(3):346-348. doi: 10.1007/s00066-024-02351-2. Epub 2025 Jan 11.

DOI:10.1007/s00066-024-02351-2

PMID:39799208

Abstract

摘要

相似文献

[Can stereotactic radiotherapy for neovascular age-related macular degeneration (STAR trial) enhance quality of life?].[立体定向放射治疗新生血管性年龄相关性黄斑变性（STAR试验）能否提高生活质量？]

Strahlenther Onkol. 2025 Mar;201(3):346-348. doi: 10.1007/s00066-024-02351-2. Epub 2025 Jan 11.

StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.湿性年龄相关性黄斑变性立体定向放射治疗（STAR）：一项随机对照临床试验的研究方案

Trials. 2016 Nov 24;17(1):560. doi: 10.1186/s13063-016-1676-7.

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives.湿性年龄相关性黄斑变性的立体定向放射治疗：当前观点

Clin Ophthalmol. 2015 Sep 28;9:1829-34. doi: 10.2147/OPTH.S75638. eCollection 2015.

Radiotherapy for neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性的放射治疗

Cochrane Database Syst Rev. 2020 Aug 26;8(8):CD004004. doi: 10.1002/14651858.CD004004.pub4.

Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration.接受立体定向分割外照射治疗新生血管性年龄相关性黄斑变性的眼睛的 10 年随访。

Retina. 2011 Jul-Aug;31(7):1303-15. doi: 10.1097/IAE.0b013e318203ee46.

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.立体定向放射治疗新生血管性年龄相关性黄斑变性（STAR）：一项关键的、随机的、双盲的、假对照设备试验。

Lancet. 2024 Jul 6;404(10447):44-54. doi: 10.1016/S0140-6736(24)00687-1. Epub 2024 Jun 11.

Stereotactic radiotherapy for wet age-related macular degeneration (INTREPID): influence of baseline characteristics on clinical response.湿性年龄相关性黄斑变性的立体定向放射治疗（INTREPID）：基线特征对临床反应的影响

Retina. 2015 Feb;35(2):194-204. doi: 10.1097/IAE.0000000000000283.

Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.老年人群中未受影响的第二眼新生血管性黄斑变性的早期无创性检测：EDNA 诊断准确性研究。

Health Technol Assess. 2022 Jan;26(8):1-142. doi: 10.3310/VLFL1739.

Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients.黄斑中心凹下脉络膜毛细血管、萨特勒层和哈勒层厚度可预测新生血管性年龄相关性黄斑变性患者立体定向放射治疗的临床反应。

J Curr Ophthalmol. 2019 Jan 2;31(1):92-94. doi: 10.1016/j.joco.2018.12.004. eCollection 2019 Mar.

Colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration.高风险新生血管性年龄相关性黄斑变性眼的颜色对比敏感度。

Eur J Ophthalmol. 2020 Nov;30(6):1487-1494. doi: 10.1177/1120672119866386. Epub 2019 Aug 14.

本文引用的文献

Lancet. 2024 Jul 6;404(10447):44-54. doi: 10.1016/S0140-6736(24)00687-1. Epub 2024 Jun 11.

Three-year clinical and optical coherence tomography follow-up after stereotactic radiotherapy for neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性的立体定向放射治疗后 3 年的临床和光学相干断层扫描随访。

Adv Med Sci. 2021 Mar;66(1):215-220. doi: 10.1016/j.advms.2021.03.002. Epub 2021 Mar 14.

Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD.脉络膜新生血管性年龄相关性黄斑变性接受立体定向放射治疗并持续玻璃体内抗 VEGF 治疗后的微血管异常及长期疗效。

Br J Ophthalmol. 2022 Mar;106(3):415-421. doi: 10.1136/bjophthalmol-2020-317563. Epub 2020 Dec 21.

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.年龄相关性黄斑变性患者玻璃体内注射后感染性和非感染性眼内炎的发生率和结局。

Ophthalmology. 2018 Jan;125(1):66-74. doi: 10.1016/j.ophtha.2017.07.005. Epub 2017 Aug 8.

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测：系统回顾和荟萃分析。

Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.

Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.立体定向放射治疗新生血管性年龄相关性黄斑变性：INTREPID 研究的 52 周安全性和疗效结果。

Ophthalmology. 2013 Sep;120(9):1893-900. doi: 10.1016/j.ophtha.2013.02.016. Epub 2013 Mar 13.

Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study.远距离治疗年龄相关性黄斑中心凹下新生血管膜的初步研究。

Br J Ophthalmol. 1993 May;77(5):265-73. doi: 10.1136/bjo.77.5.265.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验